Executives On The Move: Changes At GlaxoSmithKline, aTyr Pharma And More
Recent executive changes in the industry include the appointment of a new vice president of human resources at aTyr Pharma and promotions at Zhejiang Shapuaisi Pharmaceutical. Meanwhile, new directors were appointed at GlaxoSmithKline and Dicerna Pharmaceuticals, among others.
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Recent executive changes in the industry include the appointment of a new CEO at Medivir and promotions at Idorsia. Meanwhile, new directors were appointed at Reneo Pharmaceuticals, among others.
Coronavirus Update: As Pfizer/BioNTech Begin Omicron Vaccine Tests, Regulators Want To Explore Multivalent Route
Pfizer explores options for new vaccine update, Veklury expands to non-hospitalized patients but Regeneron and Lilly therapies stopped in face of Omicron efficacy drop-off.